Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Low-frequency parietal repetitive transcranial magnetic stimulation reduces fear and anxiety


Anxiety disorders are the most prevalent mental disorders, with few effective neuropharmacological treatments, making treatments development critical. While noninvasive neuromodulation can successfully treat depression, few treatment targets have been identified specifically for anxiety disorders. Previously, we showed that shock threat increases excitability and connectivity of the intraparietal sulcus (IPS). Here we tested the hypothesis that inhibitory repetitive transcranial magnetic stimulation (rTMS) targeting this region would reduce induced anxiety. Subjects were exposed to neutral, predictable, and unpredictable shock threat, while receiving double-blinded, 1 Hz active or sham IPS rTMS. We used global brain connectivity and electric-field modelling to define the single-subject targets. We assessed subjective anxiety with online ratings and physiological arousal with the startle reflex. Startle stimuli (103 dB white noise) probed fear and anxiety during the predictable (fear-potentiated startle, FPS) and unpredictable (anxiety-potentiated startle, APS) conditions. Active rTMS reduced both FPS and APS relative to both the sham and no stimulation conditions. However, the online anxiety ratings showed no difference between the stimulation conditions. These results were not dependent on the laterality of the stimulation, or the subjects’ perception of the stimulation (i.e. active vs. sham). Results suggest that reducing IPS excitability during shock threat is sufficient to reduce physiological arousal related to both fear and anxiety, and are consistent with our previous research showing hyperexcitability in this region during threat. By extension, these results suggest that 1 Hz parietal stimulation may be an effective treatment for clinical anxiety, warranting future work in anxiety patients.


Anxiety disorders are the most commonly diagnosed class of mental disorders. Nearly 20% of the US population meets the criteria for an anxiety disorder within a given year, and less than half of those individuals receive minimally adequate treatment for their disorder1. One potential reason for this lack of treatment efficacy is that clinical anxiety is comprised of an array of complex symptoms involving cognitive and behavioral domains2, however, much of the mechanistic anxiety research remains focused on a narrow set of subcortical regions, such as the amygdala and the bed nucleus of the stria terminalis3,4,5. Therefore, in order to better understand and treat clinical anxiety, it is important to broaden the scope of the research into anxiety mechanisms, and develop treatment options specifically targeted at these mechanisms.

One avenue for novel treatments is transcranial magnetic stimulation (TMS),which is a is a noninvasive neuromodulation approach that uses brief magnetic pulses generated at the scalp to induce electrical currents in the underlying cortical neurons6. Repetitive TMS (rTMS), which was recently approved by the FDA to treat depression7, uses repeated stimulation of a specific region to induce long-lasting changes in cortical excitability8. In motor cortex, high-frequency stimulation (>5 Hz) increases cortical excitability, while low-frequency stimulation decreases cortical excitability9,10,11. Using this approach it is possible to target specific regions of the cortex with high spatial and temporal accuracy.

Previous studies using electroencephalography (EEG) have demonstrated hyperactivity in the parietal cortex as a function of arousal in anxious patients12, suggesting a potential link between parietal hyperactivity and attention control deficits13. Consistent with these results, our previous work used unbiased data-driven approaches in a multimodal (MEG/fMRI) neuroimaging study of effects of threat-of-shock-induced anxiety on cortical excitability (alpha desynchronization) and global brain connectivity14. In that study, we found evidence for increases in both excitability and functional connectivity of the intraparietal sulcus in anxious subjects anticipating the shock.

Based on these results, we hypothesized that the parietal cortex may be an effective target for noninvasive neuromodulation. In this study, we targeted the IPS with low-frequency rTMS to reduce parietal hyperexcitability during anxiety. We then measured the effect of this stimulation protocol on fear- and anxiety-potentiated startle during the Neutral, Predictable, and Unpredictable threat task (NPU), which explores defense responses to predictable and unpredictable threat15,16. We hypothesized that low-frequency stimulation of the parietal cortex would decrease the heightened orienting to the white noise threat, and that this would attenuate potentiated startle observed during the threat periods.

Materials and methods


Sample size was based on our previous study exploring the effect of right dlPFC rTMS on anxiety, which used a similar design17. Twenty-five participants were enrolled in the study. All subjects met the inclusion/exclusion criteria, which included: aged 18–50, English speaking, no Axis I diagnosis18, no medication use, no neurological issues, and no MRI/TMS contraindications. Of the enrolled subjects, seven were withdrawn from the study for the following reasons: one subject was unable to attend all study sessions, one subject was not compliant during the TMS procedure, one subject had neurological condition revealed on the MRI scan, the equipment failed for one subject, we were unable to find the motor threshold for one subject, and one subject had an abnormally low percentage of startle responses to the white noise presentations (<30%). The remaining 19 subjects (mean age = 29.11 years, SD = 8.47), included 13 females. All participants gave written informed consent approved by the National Institute of Mental Health (NIMH) Combined Neuroscience Institutional Review Board and were compensated for their time.

NPU procedure

NPU threat task

We used the neutral, predictable, unpredictable threat task to induce fear and anxiety (see Fig. 1). The NPU task consisted of three runs15. Within each run, there were several blocks of neutral (no shock), predictable (at risk for shock only during cue), and unpredictable blocks (at risk for shock at all times). Within each block, there were several trials where a cue (shape) was presented for 8 s. Cues were simple colored (orange, teal, purple) geometric shapes (triangle, square, pentagon), with color and shape randomly assigned to conditions. White noise probes were presented during each cue presentation, and during an equal number of trial interval (ITI) periods. White noise probes were presented every ~17 ± 4 s. Three shocks were presented in each run at a random point during either the cue (predictable condition) or the ITI (unpredictable condition). To measure anxiety, we recorded the amplitude of the blink response elicited by the white noise. We also measured anxiety using a concurrent continuous rating scale. The three runs differed based on the stimulation type. During one run, subjects received 1 Hz active rTMS. During another, they received 1 Hz sham rTMS. During a third, they received 1 Hz tone presentations (a “no TMS” control). The order of the runs were counterbalanced across subjects, and both the operator and the subject were blinded to the type of stimulation (active vs. sham) during the active and sham runs. White noises and shocks were embedded in the TMS/tone series by replacing the TMS pulse (or tone) at random points during the blocks.

Fig. 1: Design Schematic and overall results.

a Schematic of the neutral predictable unpredictable (NPU) threat task with online 1 Hz repetitive transcranial magnetic stimulation (rTMS). Subjects were exposed to neutral (N), predictable (P), and unpredictable (U) conditions. During the entire run subjects receive 1 Hz active rTMS, sham rTMS, or no TMS (tones). Startle probes and shocks were embedded in this 1 Hz train at random intervals during the cue (shape) period or inter trial interval (ITI). b Startle responses during the cue and ITI periods of the NPU task as a function of rTMS type. c Concurrent anxiety ratings collected during the NPU task and sampled during the cue and ITI periods as a function of rTMS type. TMS coil icons represent TMS pulses. Green noise traces represent white noise presentations. Lightning bolts represent shocks. Bars represent mean ± standard error.

White noise

The startle stimulus was a 40-ms, 103-dB white noise with an instantaneous rise time19. Because the white noise needed to be delivered during the rTMS, subjects required headphones with hearing protection. Therefore, subjects wore custom headphones fabricated from noise-cancelling ear muffs with a noise reduction rating of 30 dB (3 M Optime 105; Minneapolis, MN). Prior to the runs, subjects were exposed to nine unsignaled presentations of the white noise with a variable inter-noise interval of ~17 s to reduce initial startle reactivity.


The shock was a 100 ms, 200 Hz train of stimulation delivered to the right wrist via 2, 11 mm disposable Ag/AgCl electrodes (Biopac Item number EL508; Goleta, CA), spaced ~2 cm apart using a constant current stimulator (Digitimer #DS7A, Ft. Lauderdale, FL). Shock intensity (M = 3.74 mA; SD = 3.07 mA) was set to a level that subjects rated as “uncomfortable but tolerable”.


Facial electromyography (EMG) startle responses were recorded from the left orbicularis oculi muscle via 15 × 20 mm hydrogel coated vinyl electrodes (Rhythmlink #DECUS10026; Columbia, SC), and the EMG signal was sampled at 2000 Hz using a Biopac MP160 unit (Biopac; Goleta, CA).

Startle measure

The EMG signal was filtered from 30 to 300 Hz, then rectified and smoothed using a 20-ms sliding window. Responses were scored as the peak (20–120 ms)—the baseline (−50 to 0 ms), and converted to t-scores (tx = [Zx × 10] + 50). Trials with excessive noise (baseline SD > 2x run SD) were counted as missing data, and trials with no discernible blink (peak < baseline voltage amplitude range) were coded as 0.

Anxiety ratings

Subjects rated their anxiety throughout the experiment using keypresses that updated an online rating scale (from 0 [not anxious] to 10 [extremely anxious]). This was sampled at each white noise presentation, and averaged across trials.

rTMS procedure

Motor threshold determination

Resting motor threshold (MT) was measured in the first dorsal interosseous (FDI) muscle, and was defined as the minimum magnetic flux needed to elicit a threshold motor evoked potential (MEP) ≥ 50 µV in 5 out of 10 trials20,21. Subjects MT averaged 44.63 (SD = 8.84) percent of machine output.


Subjects received 1 Hz rTMS to either the left or right intraparietal sulcus (defined below) via a Cool-B65 A/P coil powered by a MagVenture MagPro 100 (MagVenture, Inc., Alpharetta GA) stimulator. During the active run, subjects received pulses at 100% of MT for the duration of the ~870 s run. During the sham run, subjects received the same number of pulses from the unmarked placebo side of the coil, which provides a field reduction of ~80%. Both the subject and the operator were blinded to the condition (active vs. sham). Immediately after the experiment, subjects were asked to guess which run was active and provide a confidence rating (1 [not sure] to 10 [very sure]) after the experiment.

Target localization

We based our target choice on group data from Balderston et al. (see Fig. 2a)14,16, which found increases in global connectivity in the intraparietal sulcus during threat-of-shock, suggesting that this region may be a connectivity hub mediating anxiety expression. Accordingly, the goal of the present work was to extract the location within this region with the highest global connectivity. We then used electric-field modelling to optimize coil placement (See Fig. 2b), and online neuronavigation to ensure accurate stimulation.

Fig. 2: Schematic of targeting and electric- (e) field modelling methods.

a 10 mm spheres drawn around peak global brain connectivity coordinates from Balderston et al. 14,16, overlaid on MNI template Red circles represent search region for individual targets, which were defined at the individual subject level as the voxel within the mask with the highest global brain connectivity. b Representation of e-field modelling approach used in the current analysis. Multiple e-field models corresponding to equally spaced coil orientations were conducted. The coil orientation that yielded the e-field model with the maximum value at the target was used during the TMS session.

MRI scans

For high-resolution structural imaging and to calculate the e-field models, we collected a T1 (Resolution = 0.8 mm; FOV = 256 × 256; Slices = 176 sagittal; TR = 2400 ms; TE = 2.24 ms; Flip angle = 7°), a T2 (Resolution = 0.8 mm; FOV = 300 × 320; Slices = 208 sagittal; TR = 3200 ms; TE = 566 ms; Flip angle = 120°), and a DWI (Resolution = 2 mm; FOV = 128 × 128; Slices = 70 axial; TR = 12000 ms; TE = 64 ms; Flip angle = 90°; B0 = 100; Directions = 30) scan. To calculate global connectivity, we collected a 10 min eyes-open, multi-echo, resting-state EPI (Resolution = 3 mm; FOV = 64 × 64; Slices = 32 axial; TR = 2000 ms; TEs = 13.8, 31.2, 48.6 ms; Flip angle = 70°) scan.

MRI/fMRI processing

Reconstruction and fMRI pre-processing was done with AFNI22,23. fMRI preprocessing included slice-timing correction, despiking, volume registration, TE-dependent independent components analysis (ICA) denoising, scaling, EPI distortion correction, motion scrubbing, and blurring with a 6 mm FWHM Gaussian kernel. Timeseries were further denoised based on regressors of no interest corresponding to the 6 motion parameters and 4 polynomial baseline estimates. MRI and DWI processing was done using the SimNIBS24 software package, which calls Freesurfer to create tissue compartments from the T1/T2 images for the skin, skull, cerebrospinal fluid, grey matter, and white matter, and FSL to compute conductivity tensors from the DWI images.

fMRI-guided target selection

To localize the optimal IPS target, we drew 10 mm spheres around the MNI coordinates reported in Balderston et al.14,16. We then calculated global connectivity from the denoised resting-state EPI scan using the AFNI tool 3dTCorrMap. Finally, we extracted the voxel with the highest global connectivity, and used the coordinates as the TMS target. Importantly, because the Balderston et al.14,16 finding was bilateral, we did not constrain our search to a specific hemisphere. Therefore, we had roughly equal numbers of people receiving left (N = 9) and right (N = 10) IPS stimulation.

Electric-field optimization

Once the target coordinates were identified, they were projected to the scalp, and a simulated coil was placed tangentially to the scalp surface. We then computed a series of 24 independent electric-field models corresponding to coil positions with equally spaced yaw vectors around the target25. The simulation with the largest normalized electric-field strength estimate at the original coordinates was used to define the yaw vector (coil orientation) during stimulation.


Prior to stimulation, subjects were registered to their T1 image and target via fiducial points at the nasion and tragi. During stimulation, the relative position of the subject and coil were tracked in real-time using Brainsight (Rogue Research Inc., Montreal, Canada), a frameless stereotaxic neuronavigation system that uses reflective markers monitored with an infrared camera.



To gauge the effectiveness of our blinding procedure, we tabulated the number of subjects who correctly guessed which run was active vs. sham. Subjects correctly guessed the active run at a rate of 76.47%, which is above chance (13 of 17 with missing data for 2 subjects; Χ2 (1, N = 17) = 4.77, p = 0.029). We also calculated the confidence in these guesses, which was not significantly different from the middle point of the confidence scale (M = 6.71; SD = 2.82; t(17) = 1.71, p = 0.107). Given that subjects were able to correctly guess the active run at an above chance level, we took extra steps below to rule out any placebo effects in the analyses.


To quantify fear and anxiety, we calculated fear- and anxiety-potentiated startle (Fig. 3)15,16. For FPS, we subtracted the startle magnitude during the predictable ITI from the startle magnitude during the predictable cue. For APS, we subtracted the startle magnitude during the neutral ITI from the startle magnitude during the unpredictable ITI. We then performed a 2 (Startle type: FPS vs. APS) × 3 (Stimulation type: Active, vs. Sham, vs. No TMS) repeated measures ANOVA on the results. We found a main effect for Startle type with FPS being significantly larger than APS (f(1,18) = 8.05; p = 0.011), as well as a significant main effect for TMS (f(2,36) = 3.33; p = 0.047), but no interaction (f(2,36) = 0.36; p = 0.701).

Fig. 3: Fear and anxiety-potentiated startle results.

a Fear and anxiety-potentiated startle (FPS and APS, respectively) as a function of repetitive transcranial magnetic stimulation (rTMS) type. b Potentiated startle (average of FPS and APS) as a function of rTMS type. Active 1 Hz rTMS to the parietal cortex significantly reduces potentiated startle compared to both sham and no TMS conditions. Bars represent mean ± standard error. *p > 0.05.

To characterize the main effect of TMS, we averaged across startle type and conducted three post hoc t-tests. Potentiated startle was significantly reduced in the active condition compared to both the sham (Active vs. Sham: t(18) = 2.38; p = 0.028) and the No TMS (Active vs. No TMS: t(18) = 2.31; p = 0.033) conditions, but no difference between the sham and the No TMS (Sham vs. No TMS: t(18) = 0.42; p = 0.677) conditions. Given that subjects were able to guess the active run at an above chance level, we combined subjects’ accuracy and confidence ratings into a continuous measure ranging from −1 (sure, but incorrect) to 1 (sure and correct), and included this in the original ANOVA. Importantly, the main effect of TMS was still significant (f(2,34) = 3.489; p = 0.042) and there were no significant main effects or interactions with our accuracy/confidence measure (ps > 0.05). Similarly, if we rerun the Active vs. Sham, Active vs. No TMS, and Sham vs. No TMS t-tests above as repeated-measures ANOVAs with accuracy/confidence as a covariate, we still observe significant main effects for the Active vs. Sham (f(1,17 = 8.376; p = 0.010) and Active vs. No TMS (f(1,17 = 4.569; p = 0.047) comparisons, and no main effect for the Sham vs. No TMS (f(1,17 = 0.011; p = 0.918) comparison. In addition, we found no significant main effects or interactions with accuracy/confidence in any of the ANOVAs (ps > 0.05). In addition, to test for laterality effects, we re-ran the original ANVOA adding hemisphere as a between-subjects measure, and found no significant main effects or interactions with this variable (all ps > 0.05).


As with startle, we quantified fear and anxiety from the online ratings, using the same equations described above (Fear: P cue – P ITI; Anxiety U ITI – N ITI). We then performed a 2 (Startle type: FPS vs. APS) × 3 (Stimulation type: Active, vs. Sham, vs. No TMS) repeated measures ANOVA on the results. As with startle, we found a significant main effect of fear vs. anxiety (f(1,18) = 37.85; p < 0.001). However, this effect was in the opposite direction with ratings being higher for anxiety compared to fear. In contrast, we found no main effect for TMS type (f(2,36) = 0.64; p = 0.532) and no interaction (f(2,36) = 1.44; p = 0.251).


We administered online 1-Hz rTMS to the parietal cortex during the NPU threat task. We measured fear and anxiety through potentiated startle responses and concurrent on-screen anxiety ratings. We found that rTMS reduced both fear- and anxiety-potentiated startle, but did not affect the online anxiety ratings. We also found that these results were unaffected by the laterality of the stimulation, or the individual’s ability to distinguish between active and sham stimulation. Together these results suggest that the parietal cortex plays a causal role in the elevated arousal that mediates potentiated startle responses, and that inhibiting activity using low-frequency rTMS is sufficient to reduce physiological arousal associated with fear and anxiety during threat. They also have implications for the use of noninvasive neuromodulation for the treatment of anxiety disorders. These points will be addressed below.

It is known that anxiety can impact attention control26, and that anxiety patients have trouble focusing attention27,28. This manifests in deficits in a variety of cognitive tasks, including working memory29,30,31. Importantly, the parietal cortex is critical for endogenous shifts in attention32,33,34. It also receives top-down feedback from the dlPFC during working memory manipulation35, playing a critical role in the maintenance of structured information36. This coordinated frontoparietal activity, in conjunction with the default mode network, has also been associated with the maintenance of internal thought37. Together these results suggest that the parietal cortex may be involved with endogenous shifts in attention toward threat during the NPU task. Therefore, by inhibiting parietal cortex activity during the NPU task, it is possible that we were reducing subjects’ tendency to shift their attention toward the shock threat, thereby reducing their threat-related anxiety.

This threat-related hypervigilance is a prominent symptom of clinical anxiety, cutting across multiple diagnoses2, and these results suggest that it may be mediated by a hyperactive parietal cortex33,34,36,38,39. This diminished attention control may explain why (1) individuals with specific phobias may show attentional biases to threatening information40,41,42,43, (2) generalized anxiety disorder (GAD) patients have difficulties maintaining attentional focus44,45,46,47 anxiety interferes with the manipulation of items in working memory29. If this is the case, then inhibitory parietal rTMS should also reduce the attention bias to threat seen in anxiety patients. Furthermore, we would predict that this rTMS protocol could be combined with conventional attention bias modification therapies to boost their efficacy.

Low-frequency rTMS of right parietal cortex leads to decreases in depressed mood and attentional bias to fearful faces48, and extended treatment with low-frequency right parietal stimulation leads to better emotion expression recognition in depressed patients49. However, it should be noted that extended treatment with this stimulation protocol did not lead to a significant reduction in depression symptoms in a recent clinical trial50. Future research needs to be conducted to explore the suitability of parietal inhibition for anxiety reduction. What does seem clear is that rTMS to posterior parietal regions affects attentional processes, particularly orienting. For instance, on recent study showed that stimulation of the right dorsal posterior parietal cortex resulted in enhancement in cued target detection when images are presented to the right hemifield51. These results are consistent with the hypervigilance hypothesis stated above, suggesting that targeting parietal regions during periods of elevated anxiety may reduce the hypervigilance experienced by anxiety patients, and may reduce attentional biases to threat stimuli.

One surprising finding in the current study is that we observed reductions in potentiated startle, but not anxiety ratings. Indeed, we generally expect a high correspondence between startle and ratings across experimental conditions. However, there is a precedent for dissociations between physiological and psychological expressions of fear and anxiety52,53,54,55. At a more fundamental level, we understand that anxiety is multifaceted, engaging multiple neural networks56, and encompassing a variety of distinct symptom domains2. The current manipulation, threat of predictable and unpredictable shock, can induce robust increases in physiological arousal15,16, impairments in performance on tasks that require working memory processes57,58, and improvements in tasks that require sustained attention59. Accordingly, it is clear that instructed threat impacts behavior across multiple domains important for anxiety symptomatology60. However, the benefit of TMS as an intervention is that one can potentially selectively target distinct symptom domains at the individual level. More work is definitely needed, but parietal inhibition may propose promise as a future treatment in its own right, or as an add-on to existing treatments.

Although our current results suggest a promising role for parietal inhibition in the treatment of anxiety, the majority of the anxiety-related rTMS research is focused on prefrontal stimulation. In general, researchers tend to manipulate the site of stimulation (left vs. right) and the frequency of stimulation (low-frequency vs. high frequency). High frequency left dlPFC stimulation and low-frequency right dlPFC stimulation tend to enhance anxiety regulation61,62,63,64,65,66,67, while high-frequency stimulation to the right dlPFC tends to enhance anxiety expression68,69,70. However, this distinction is not universal71,72,73. Consistent with this laterality effect, we recently measured fear- and anxiety-potentiated startle before and after 10 Hz stimulation to the right dlPFC, and found that 10 Hz stimulation increased anxiety-potentiated startle, suggesting that the right dlPFC may be important for anxiety expression rather than regulation17.

Importantly, frontoparietal interactions may be important for treatment response. Connectivity based parcellation shows that the IPS is strongly connected to prefrontal regions important for attentional processes74. Indeed, our previous results suggest that this region may be a cortical connectivity hub14. Together these results suggest that targeting parietal cortex may impact frontal circuits, and vice versa. Consistent with this hypothesis, stimulation to the IPS, which shows strong prefrontal connections, lead to impairments on a stop signal task compared to stimulation of the tempoparietal junction, an area not connected to the prefrontal cortex74. Also consistent with this network hypothesis of TMS effects, recent work has shown that prefrontal stimulation alters parietal activity75, and that the therapeutic effects of prefrontal stimulation may be mediated in part through these changes in parietal activity76.

There is increased interest in applications of noninvasive neuromodulation for the treatment of psychiatric disorders since rTMS was approved by the FDA for the treatment of depression7. Although there have been several clinical trials exploring the application of rTMS for the treatment of anxiety both as a symptom and as a disorder66,77,78,79, these clinical trials were largely based on the stimulation protocols developed for depression. These protocols, which largely rely on frontal stimulation80,81,82,83,84, are based on observations of asymmetric cortical EEG responses in depressed individuals85,86, and may not be optimally designed for the treatment of anxiety87. They also have the added limitation that they are often unpleasant or painful for patients, and may lead to more anxiety acutely88.

This research is a potential first step in the development of an anxiety-specific rTMS treatment protocol. We targeted our stimulation to a parietal region shown in previous neuroimaging work to be specifically involved in anxiety expression14. We used the combination of shock threat as a manipulation and potentiated startle as an outcome measure. Threat effects have been shown to be reliable both within session and across sessions89,90,91. Likewise, startle responses have also been shown to track well with clinical symptoms in pharmacological intervention studies, demonstrating external validity89,91,92,93. Finally, given that there are fewer peripheral off-target effects with parietal over frontal stimulation, this work also has the added benefit of greater tolerability, which may impact future treatment adherence. Together with the current rTMS results, these points suggest that the rTMS protocol used in this study has the potential to be an effective treatment for clinical anxiety, necessitating a great deal of additional research.

Future directions

In this work, we discovered a novel application of rTMS that reduced threat-related anxiety in healthy volunteers. As mentioned above, these results have the potential to inform novel neuromodulatory treatments of clinical anxiety, however, the pathway to this aim will require several additional studies using both healthy volunteers, and ultimately patients. As a next step, it will be important to identify the mechanism of this anxiety reduction using simultaneous rTMS-fMRI, which will provide information about the downstream effects of parietal rTMS. Next, it will be important to determine the extent to which 1 Hz rTMS to the parietal cortex can induce long-lasting changes in parietal activity. For this, it will be important to conduct multiple neuromodulation sessions to generate a cumulative effect of the stimulation, and then test the effects in a subsequent post-neuromodulation test session. In addition, there should be sufficient time between the last neuromodulation session and the test to ensure that the acute effects of the rTMS are no longer active. Finally, it will be important to test this protocol in a large-scale clinical trial with generalized anxiety disorder patients.

Strengths and limitations

There were several strengths to the current study. First, we used a reliable and validated approach to induce and measure anxiety in healthy volunteers. Second, we targeted a neurophysiological process engaged by acute anxiety, supported by evidence from multiple neuroimaging modalities. Third, we targeted this process at the individual level using a novel application of global brain connectivity to identify the local parietal connectivity hub. Finally, we optimized the stimulation by using e-field modelling to determine the optimal coil orientation for each subject, and tracked the position/orientation of the coil in real time using online neuronavigation.

Weaknesses should also be considered. First, subjects were able to distinguish between active and sham stimulation at an above chance level. Adequate blinding in rTMS studies is critical, and ensuring that the sensation is similar between active and sham stimulation is one approach to ensuring blinding. In our study we attempted to deliver an electric stimulus simultaneous to the TMS pulse in the sham condition (electrodes were attached in both active and sham). However, we used vinyl stickypad electrodes, because thicker electrodes would interfere with stimulation, and it was difficult to get a reliable connection with the scalp using these. Future studies might use low-profile EEG electrodes held in place under a swim cap to decrease the impedance. Because of this, it is important to consider whether the current results were due to subjects’ expectations. Given that (1) there was no effect of active stimulation on concurrent anxiety ratings, and (2) there was no effect of subjects’ perception of active/sham order on potentiated startle responses, our results suggest that the finding of reduced potentiated startle during the active stimulation was not due to subject demand characteristics. Another limitation of the current study is the relatively low sample size (N = 19); however, we used a within-subject design and observed a medium to large effect size that was consistent for both fear- and anxiety-potentiated startle. It is important to note that effect sizes can be overestimated with such small samples, and future studies should increase their sample size to ensure an accurate estimation of the true effects. As additional, clinical research using this stimulation protocol is conducted, it will be important to increase the sample size of the studies to a level more appropriate for a clinical trial. In the meantime, it should be noted that we used a within subject active/sham/control comparison to maximize power, and counterbalanced the order to minimize the carryover effects.


This study found that low-frequency rTMS to the parietal cortex reduced fear and anxiety, as measured with startle. As a result, we believe that this stimulation protocol has promise in the development of a potential treatment for anxiety disorders. As a potential treatment, it has at least two advantages over current rTMS treatments. First, it is being developed specifically for anxiety. Second, there are fewer unpleasant off-target effects compared to frontal stimulation. Future clinical trials should be conducted to ensure that this stimulation protocol can affect long-lasting changes in symptoms experienced by anxiety patients.


  1. 1.

    Wang, P. S. et al. Twelve-month use of mental health services in the United States. Am. Med Assoc. 62, 629–640 (2005).

    Google Scholar 

  2. 2.

    American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders: Dsm-5. (Amer Psychiatric Pub Incorporated, Arlington, 2013).

  3. 3.

    Adhikari, A. Distributed circuits underlying anxiety. Front Behav. Neurosci. 8, 1–6 (2014).

    Google Scholar 

  4. 4.

    Davis, M., Walker, D. L., Miles, L. & Grillon, C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology 35, 105–135 (2010).

    PubMed  Google Scholar 

  5. 5.

    Torrisi, S. et al. Extended amygdala connectivity changes during sustained shock anticipation. Transl Psychiatry. (2017).

  6. 6.

    Klomjai, W., Katz, R. & Lackmy-Vallée, A. Basic principles of transcranial magnetic stimulation (TMS) and repetitive TMS (rTMS). Ann. Phys. Rehabil. Med. 58, 208–213 (2015).

    PubMed  Google Scholar 

  7. 7.

    O’Reardon, J. P. et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol. Psychiatry 62, 1208–1216 (2007).

    PubMed  Google Scholar 

  8. 8.

    Fitzgerald, P. B., Fountain, S. & Daskalakis, Z. J. A comprehensive review of the effects of rTMS on motor cortical excitability and inhibition. Clin. Neurophysiol. 117, 2584–2596 (2006).

    PubMed  Google Scholar 

  9. 9.

    Rubens, M. T. & Zanto, T. P. Parameterization of transcranial magnetic stimulation. J. Neurophysiol. 107, 1257–1259 (2011).

    PubMed  PubMed Central  Google Scholar 

  10. 10.

    Di Lazzaro, V. et al. Modulation of motor cortex neuronal networks by rTMS: comparison of local and remote effects of six different protocols of stimulation. J. Neurophysiol. 105, 2150–2156 (2011).

    PubMed  Google Scholar 

  11. 11.

    Pascual-Leone, A., Valls-Solé, J., Wassermann, E. M. & Hallett, M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 117, 847–858 (1994).

    PubMed  Google Scholar 

  12. 12.

    Nitschke, J. B., Heller, W., Palmieri, P. A. & Miller, G. A. Contrasting patterns of brain activity in anxious apprehension and anxious arousal. Psychophysiology 36, 628–637 (1999).

    CAS  PubMed  Google Scholar 

  13. 13.

    Frank, D. W. & Sabatinelli, D. Stimulus-driven reorienting in the ventral frontoparietal attention network: the role of emotional content. Front Hum. Neurosci. 6, 1–5 (2012).

    Google Scholar 

  14. 14.

    Balderston, N. L. et al. Threat of shock increases excitability and connectivity of the intraparietal sulcus. Elife. 6, (2017).

  15. 15.

    Schmitz, A. & Grillon, C. Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test). Nat. Protoc. 7, 527–532 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Balderston, N. L., Liu, J., Roberson-Nay, R., Ernst, M., Grillon, C. The relationship between dlPFC activity during unpredictable threat and CO2-induced panic symptoms. Transl Psychiatry. 7, (2017).

  17. 17.

    Balderston, N. L. et al. Mechanistic link between right prefrontal cortical activity and anxious arousal revealed using transcranial magnetic stimulation in healthy subjects. Neuropsychopharmacology. (2019).

  18. 18.

    First, M. B., Spitzer, R. L., Gibbon, M., Williams, J. B. W. Structured Clinical Interview for DSM-IV®Axis I Disorders (SCID-I), Clinician Version, Administration Booklet. (American Psychiatric Publishing, 2012)

  19. 19.

    Blumenthal, T. D. et al. Committee report: guidelines for human startle eyeblink electromyographic studies. Psychophysiology 42, 1–15 (2005).

    PubMed  Google Scholar 

  20. 20.

    Luber, B. M. et al. Extended remediation of sleep deprived-induced working memory deficits using fMRI-guided transcranial magnetic stimulation. Sleep 36, 857–871 (2013).

    PubMed  PubMed Central  Google Scholar 

  21. 21.

    Luber, B. M. et al. Remediation of sleep-deprivation-induced working memory impairment with fMRI-guided transcranial magnetic stimulation. Cereb. Cortex 18, 2077–2085 (2008).

    CAS  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Cox, R. W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed. Res 29, 162–173 (1996).

    CAS  PubMed  Google Scholar 

  23. 23.

    Kundu, P., Inati, S. J., Evans, J. W., Luh, W. M. & Bandettini, P. A. Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI. Neuroimage 60, 1759–1770 (2012).

    PubMed  PubMed Central  Google Scholar 

  24. 24.

    Thielscher, A., Antunes, A., Saturnino, G. B. Field modeling for transcranial magnetic stimulation: A useful tool to understand the physiological effects of TMS? 37th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC), Milan, 222–225 (2015).

  25. 25.

    Opitz, A., Fox, M. D., Craddock, R. C., Colcombe, S. & Milham, M. P. An integrated framework for targeting functional networks via transcranial magnetic stimulation. Neuroimage 127, 86–96 (2016).

    PubMed  Google Scholar 

  26. 26.

    Eysenck, M. W., Derakshan, N., Santos, R. & Calvo, M. G. Anxiety and cognitive performance: attentional control theory. Emotion 7, 336–353 (2007).

    PubMed  Google Scholar 

  27. 27.

    Rapee, R. M. Generalized anxiety disorder: a review of clinical features and theoretical concepts. Clin. Psychol. Rev. 11, 419–440 (1991).

    Google Scholar 

  28. 28.

    Price, R. B., Eldreth, Da & Mohlman, J. Deficient prefrontal attentional control in late-life generalized anxiety disorder: an fMRI investigation. Transl. Psychiatry 1, e46 (2011).

    CAS  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Balderston, N. L. et al. Anxiety patients show reduced working memory related dlpfc activation during safety and threat. Depress Anxiety 12, 1–12 (2016).

    Google Scholar 

  30. 30.

    Vytal, K. E., Arkin, N. E., Overstreet, C., Lieberman, L. & Grillon, C. Induced-anxiety differentially disrupts working memory in generalized anxiety disorder. BMC Psychiatry 16, 62 (2016).

    PubMed  PubMed Central  Google Scholar 

  31. 31.

    Robinson, O., Vytal, K. E., Cornwell, B. R. & Grillon, C. The impact of anxiety upon cognition: perspectives from human threat of shock studies. Front Hum. Neurosci. 7, 203 (2013).

    PubMed  PubMed Central  Google Scholar 

  32. 32.

    Du, X., Chen, L. & Zhou, K. The role of the left posterior parietal lobule in top-down modulation on space-based attention: a transcranial magnetic stimulation study. Hum. Brain Mapp. 33, 2477–2486 (2012).

    PubMed  Google Scholar 

  33. 33.

    Rushworth, M. F. S., Nixon, P. D., Renowden, S., Wade, D. T. & Passingham, R. E. The left parietal cortex and motor attention. Neuropsychologia 35, 1261–1273 (1997).

    CAS  PubMed  Google Scholar 

  34. 34.

    Molenberghs, P., Mesulam, M. M., Peeters, R. & Vandenberghe, R. R. C. Remapping attentional priorities: differential contribution of superior parietal lobule and intraparietal sulcus. Cereb. Cortex 17, 2703–2712 (2007).

    PubMed  Google Scholar 

  35. 35.

    Brass, M., Ullsperger, M., Knoesche, T. R., von Cramon, D. Y. & Phillips, N. A. Who comes first? The role of the prefrontal and parietal cortex in cognitive control. J. Cogn. Neurosci. 17, 1367–1375 (2005).

    PubMed  Google Scholar 

  36. 36.

    Wendelken, C., Bunge, Sa & Carter, C. S. Maintaining structured information: an investigation into functions of parietal and lateral prefrontal cortices. Neuropsychologia 46, 665–678 (2008).

    PubMed  Google Scholar 

  37. 37.

    Smallwood, J., Brown, K., Baird, B. & Schooler, J. W. Cooperation between the default mode network and the frontal-parietal network in the production of an internal train of thought. Brain Res. 1428, 60–70 (2012).

    CAS  PubMed  Google Scholar 

  38. 38.

    Grimault, S. et al. Oscillatory activity in parietal and dorsolateral prefrontal cortex during retention in visual short-term memory: additive effects of spatial attention and memory load. Hum. Brain Mapp. 30, 3378–3392 (2009).

    PubMed  PubMed Central  Google Scholar 

  39. 39.

    Sandrini, M., Fertonani, A., Cohen, L. G. & Miniussi, C. Double dissociation of working memory load effects induced by bilateral parietal modulation. Neuropsychologia 50, 396–402 (2012).

    PubMed  Google Scholar 

  40. 40.

    Niles, A. N., Mesri, B., Burklund, L. J., Lieberman, M. D. & Craske, M. G. Attentional bias and emotional reactivity as predictors and moderators of behavioral treatment for social phobia. Behav. Res Ther. 51, 669–679 (2013).

    PubMed  Google Scholar 

  41. 41.

    Waters, A. M., Bradley, B. P. & Mogg, K. Biased attention to threat in paediatric anxiety disorders (generalized anxiety disorder, social phobia, specific phobia, separation anxiety disorder) as a function of ‘distress’ versus ‘fear’ diagnostic categorization. Psychol. Med 44, 607–616 (2014).

    CAS  PubMed  Google Scholar 

  42. 42.

    Kuckertz, J. M. & Amir, N. Attention bias modification for anxiety and phobias: current status and future directions. Curr. Psychiatry Rep. 17, 9 (2015).

    PubMed  Google Scholar 

  43. 43.

    Pergamin-Hight, L., Naim, R., Bakermans-Kranenburg, M. J., van IJzendoorn, M. H. & Bar-Haim, Y. Content specificity of attention bias to threat in anxiety disorders: a meta-analysis. Clin. Psychol. Rev. 35, 10–18 (2015).

    PubMed  Google Scholar 

  44. 44.

    Li, Y. et al. Source analysis of P3a and P3b components to investigate interaction of depression and anxiety in attentional systems. Sci. Rep. 5, 17138 (2015).

    CAS  PubMed  PubMed Central  Google Scholar 

  45. 45.

    MacNamara, A. & Hajcak, G. Distinct electrocortical and behavioral evidence for increased attention to threat in generalized anxiety disorder. Depress. Anxiety 27, 234–243 (2010).

    PubMed  Google Scholar 

  46. 46.

    Silton, R. L. et al. Depression and anxious apprehension distinguish frontocingulate cortical activity during top-down attentional control. J. Abnorm Psychol. 120, 272–285 (2011).

    PubMed  PubMed Central  Google Scholar 

  47. 47.

    Najmi, S., Amir, N., Frosio, K. E. & Ayers, C. The effects of cognitive load on attention control in subclinical anxiety and generalised anxiety disorder. Cogn. Emot. 9931, 1–14 (2014).

    Google Scholar 

  48. 48.

    van Honk, J., Schutter, D., Putman, P., de Haan, E. H. & D’Alfonso, A. A. Reductions in phenomenological, physiological and attentional indices of depressive mood after 2 Hz rTMS over the right parietal cortex in healthy human subjects. Psychiatry Res. 120, 95–101 (2003).

    PubMed  Google Scholar 

  49. 49.

    Schutter, D. J. L. G., van Honk, J., Laman, M., Vergouwen, A. C. & Koerselman, F. Increased sensitivity for angry faces in depressive disorder following 2 weeks of 2-Hz repetitive transcranial magnetic stimulation to the right parietal cortex. Int. J. Neuropsychopharmacol. 13, 1155–1161 (2010).

    PubMed  Google Scholar 

  50. 50.

    Schutter, D. J. L. G., Martin Laman, D., van Honk, J., Vergouwen, A. C. & Frank Koerselman, G. Partial clinical response to 2 weeks of 2 Hz repetitive transcranial magnetic stimulation to the right parietal cortex in depression. Int. J. Neuropsychopharmacol. 12, 643 (2009).

    PubMed  Google Scholar 

  51. 51.

    Thut, G., Nietzel, A. & Pascual-Leone, A. Dorsal posterior parietal rTMS Affects voluntary orienting of visuospatial attention. Cereb. Cortex 15, 628–638 (2005).

    PubMed  Google Scholar 

  52. 52.

    Balderston, N. L., Schultz, D. H., Baillet, S., Helmstetter, F. J. Rapid amygdala responses during trace fear conditioning without awareness. PLoS ONE. 9, (2014).

  53. 53.

    Schultz, D. H., Balderston, N. L., Geiger, J. A., Helmstetter, F. J. Dissociation between implicit and explicit responses in postconditioning ucs revaluation after fear conditioning in humans. Behav. Neurosci. 127, (2013).

  54. 54.

    Balderston, N. L., Helmstetter, F. J. Conditioning with masked stimuli affects the timecourse of skin conductance responses. Behav. Neurosci. 124, (2010).

  55. 55.

    LeDoux, J. E. Coming to terms with fear. Proc. Natl Acad. Sci. USA 111, 2871–2878 (2014).

    CAS  PubMed  Google Scholar 

  56. 56.

    Sylvester, C. M. et al. Functional network dysfunction in anxiety and anxiety disorders. Trends Neurosci. 35, 527–535 (2012).

    CAS  PubMed  PubMed Central  Google Scholar 

  57. 57.

    Vytal, K. E., Cornwell, B. R., Arkin, N. & Grillon, C. Describing the interplay between anxiety and cognition: from impaired performance under low cognitive load to reduced anxiety under high load. Psychophysiology 49, 842–852 (2012).

    PubMed  PubMed Central  Google Scholar 

  58. 58.

    Vytal, K. E., Cornwell, B. R., Letkiewicz, A. M., Arkin, N. E. & Grillon, C. The complex interaction between anxiety and cognition: insight from spatial and verbal working memory. Front Hum. Neurosci. 7, 93 (2013).

    PubMed  PubMed Central  Google Scholar 

  59. 59.

    Torrisi, S. et al. The neural basis of improved cognitive performance by threat of shock. Soc. Cogn. Affect. Neurosci. 11, (2016).

  60. 60.

    Grillon, C., Robinson, O. J., Cornwell, B., Ernst, M. Modeling anxiety in healthy humans: a key intermediate bridge between basic and clinical sciences. Neuropsychopharmacology. (2019).

  61. 61.

    Balconi, M. & Ferrari, C. RTMS stimulation on left dlpfc affects emotional cue retrieval as a function of anxiety level and gender. Depress. Anxiety 29, 976–982 (2012).

    PubMed  Google Scholar 

  62. 62.

    Balconi, M. & Ferrari, C. Left DLPFC rTMS stimulation reduced the anxiety bias effect or how to restore the positive memory processing in high-anxiety subjects. Psychiatry Res. 209, 554–559 (2013).

    PubMed  Google Scholar 

  63. 63.

    Balconi, M. & Ferrari, C. Repeated transcranial magnetic stimulation on dorsolateral prefrontal cortex improves performance in emotional memory retrieval as a function of level of anxiety and stimulus valence. Psychiatry Clin. Neurosci. 67, 210–218 (2013).

    PubMed  Google Scholar 

  64. 64.

    Ferrari, C. & Balconi, M. DLPFC implication in memory processing of affective information. A look on anxiety trait contribution. Neuropsychol. Trends 9, 53–70 (2011).

    Google Scholar 

  65. 65.

    Leyman, L., De Raedt, R., Vanderhasselt, M. A. & Baeken, C. Effects of repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex on the attentional processing of emotional information in major depression: a pilot study. Psychiatry Res. 185, 102–107 (2011).

    PubMed  Google Scholar 

  66. 66.

    White, D. & Tavakoli, S. Repetitive transcranial magnetic stimulation for treatment of major depressive disorder with comorbid generalized anxiety disorder. Ann. Clin. Psychiatry 27, 192–196 (2015).

    PubMed  Google Scholar 

  67. 67.

    Bystritsky, A. et al. A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder. J. Clin. Psychiatry 69, 1092–1098 (2008).

    PubMed  Google Scholar 

  68. 68.

    Baeken, C., Vanderhasselt, M. A. & De Raedt, R. Baseline ‘state anxiety’ influences HPA-axis sensitivity to one sham-controlled HF-rTMS session applied to the right dorsolateral prefrontal cortex. Psychoneuroendocrinology 36, 60–67 (2011).

    CAS  PubMed  Google Scholar 

  69. 69.

    Vanderhasselt, M. A., Baeken, C., Hendricks, M. & De Raedt, R. The effects of high frequency rTMS on negative attentional bias are influenced by baseline state anxiety. Neuropsychologia 49, 1824–1830 (2011).

    PubMed  Google Scholar 

  70. 70.

    Luypaert, R. et al. Neurocognitive effects of HF-rTMS over the dorsolateral prefrontal cortex on the attentional processing of emotional information in healthy women: An event-related fMRI study. Biol. Psychol. 85, 487–495 (2010).

    PubMed  Google Scholar 

  71. 71.

    Berger, C., Domes, G., Balschat, J., Thome, J. & Höppner, J. Effects of prefrontal rTMS on autonomic reactions to affective pictures. J. Neural Transm. 124, 139–152 (2017).

    PubMed  Google Scholar 

  72. 72.

    Zwanzger, P., Fallgatter, A. J., Zavorotnyy, M. & Padberg, F. Anxiolytic effects of transcranial magnetic stimulation-an alternative treatment option in anxiety disorders? J. Neural Transm. 116, 767–775 (2009).

    PubMed  Google Scholar 

  73. 73.

    Baeken, C. et al. Right prefrontal HF-rTMS attenuates right amygdala processing of negatively valenced emotional stimuli in healthy females. Behav. Brain Res. 214, 450–455 (2010).

    CAS  PubMed  Google Scholar 

  74. 74.

    Osada, T. et al. An essential role of the intraparietal sulcus in response inhibition predicted by parcellation-based network. J. Neurosci. 39, 2509–2521 (2019).

    PubMed  PubMed Central  Google Scholar 

  75. 75.

    Nord, C. L. et al. Neural predictors of treatment response to brain stimulation and psychological therapy in depression: a double-blind randomized controlled trial. Neuropsychopharmacology 44, 1613–1622 (2019).

    PubMed  PubMed Central  Google Scholar 

  76. 76.

    Al-Kaysi, A. M. et al. Predicting tDCS treatment outcomes of patients with major depressive disorder using automated EEG classification. J. Affect Disord. 208, 597–603 (2017).

    PubMed  Google Scholar 

  77. 77.

    Isserles, M. et al. Effectiveness of deep transcranial magnetic stimulation combined with a brief exposure procedure in post-traumatic stress disorder-a pilot study. Brain Stimul. 6, 377–383 (2013).

    PubMed  Google Scholar 

  78. 78.

    Mantovani, A., Aly, M., Dagan, Y., Allart, A. & Lisanby, S. H. Randomized sham controlled trial of repetitive transcranial magnetic stimulation to the dorsolateral prefrontal cortex for the treatment of panic disorder with comorbid major depression. J. Affect Disord. 144, 153–159 (2013).

    PubMed  Google Scholar 

  79. 79.

    Kozel, F. A. et al. Repetitive TMS to augment cognitive processing therapy in combat veterans of recent conflicts with PTSD: a randomized clinical trial. J. Affect Disord. 229, 506–514 (2018).

    PubMed  Google Scholar 

  80. 80.

    Aoki, Y. et al. Bilateral transcranial magnetic stimulation on DLPFC changes resting state networks and cognitive function in patients with bipolar depression. Front Hum. Neurosci. 12, 1–10 (2018).

    Google Scholar 

  81. 81.

    Concerto, C. et al. Repetitive transcranial magnetic stimulation in patients with drug-resistant major depression: a six-month clinical follow-up study. Int J. Psychiatry Clin. Pr. 19, 252–258 (2015).

    Google Scholar 

  82. 82.

    Chen, J. et al. Left versus right repetitive transcranial magnetic stimulation in treating major depression: a meta-analysis of randomised controlled trials. Psychiatry Res. 210, 1260–1264 (2013).

    PubMed  Google Scholar 

  83. 83.

    Shajahan, P. M. et al. Left dorso-lateral repetitive transcranial magnetic stimulation affects cortical excitability and functional connectivity, but does not impair cognition in major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 945–954 (2002).

    PubMed  Google Scholar 

  84. 84.

    Dell’Osso, B. et al. Augmentative repetitive transcranial magnetic stimulation (rTMS) in the acute treatment of poor responder depressed patients: a comparison study between high and low frequency stimulation. Eur. Psychiatry 30, 271–276 (2015).

    PubMed  Google Scholar 

  85. 85.

    Tomarken, A. J., Davidson, R. J., Wheeler, R. E. & Kinney, L. Psychometric properties of resting anterior EEG asymmetry: temporal stability and internal consistency. Psychophysiology 29, 576–592 (1992).

    CAS  PubMed  Google Scholar 

  86. 86.

    Davidson, R. J., Chapman, J. P., Chapman, L. J. & Henriques, J. B. Asymmetrical brain electrical activity discriminates between psychometrically-matched verbal and spatial cognitive tasks. Psychophysiology 27, 528–543 (1990).

    CAS  PubMed  Google Scholar 

  87. 87.

    Pallanti, S. & Bernardi, S. Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review. Int Clin. Psychopharmacol. 24, 163–173 (2009).

    PubMed  Google Scholar 

  88. 88.

    Klooster, D. C. W. et al. Technical aspects of neurostimulation: focus on equipment, electric field modeling, and stimulation protocols. Neurosci. Biobehav Rev. 65, 113–141 (2016).

    CAS  PubMed  Google Scholar 

  89. 89.

    Lieberman, L. et al. How many blinks are necessary for a reliable startle response? A test using the NPU-threat task. Int J. Psychophysiol. 114, 24–30 (2017).

    PubMed  PubMed Central  Google Scholar 

  90. 90.

    Grillon, C. et al. The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle. Biol. Psychiatry 60, 760–766 (2006).

    CAS  PubMed  Google Scholar 

  91. 91.

    Kaye, J. T., Bradford, D. E. & Curtin, J. J. Psychometric properties of startle and corrugator response in NPU, affective picture viewing, and resting state tasks. Psychophysiology 53, 1241–1255 (2016).

    PubMed  PubMed Central  Google Scholar 

  92. 92.

    Gorka, S. M., Liu, H., Sarapas, C. & Shankman, S. A. Time course of threat responding in panic disorder and depression. Int J. Psychophysiol. 98, 87–94 (2015).

    PubMed  PubMed Central  Google Scholar 

  93. 93.

    Bradford, D. E., Starr, M. J., Shackman, A. J. & Curtin, J. J. Empirically based comparisons of the reliability and validity of common quantification approaches for eyeblink startle potentiation in humans. Psychophysiology 52, 1669–1681 (2015).

    PubMed  PubMed Central  Google Scholar 

Download references


This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD. ( This project was supported in part by a 2018 NARSAD Young Investigator Grant from the Brain & Behavior Foundation (NLB). Financial support of this study was provided by the Intramural Research Program of the National Institute of Mental Health, ZIAMH002798 ( Identifier: NCT03027414: Protocol ID 17-M-0042). We all work at the National Institutes of Health. The views expressed here are the authors own and do not necessarily reflect the views of the NIH, DHHS, or the US Federal Government.

Author information



Corresponding author

Correspondence to Nicholas L. Balderston.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Balderston, N.L., Beydler, E.M., Goodwin, M. et al. Low-frequency parietal repetitive transcranial magnetic stimulation reduces fear and anxiety. Transl Psychiatry 10, 68 (2020).

Download citation

Further reading


Quick links